-
2008
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
-
Product Pipeline
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
AVE0010/ZP10 Publications
Thorkildsen, C., Neve, S., Larsen, B. D., Meier, E., and Pedersen, J. S.:
GLP-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.
J. Pharmacol. Exp. Ther., 2003. Vol. 307, No. 2, pp 490-496
Petersen, J.S., Thorkildsen, C., Lundgren, K. and Neve, S.: '
ZP10 - A new GLP-1 agonist that prevents diabetes progression and increases insulin mRNA expression in db/db mice.
38th Annual Meeting of the European Association for the Study of Diabetes (EASD) Budapest, Hungary; 1st - 5th September 2002
Diabetologia, 2002, 45 (Suppl. 1), A147, Abstract no. 447.
Poster presentation
Thorkildsen, C., Petersen, J.S.,Neve, S.:
ZP10 – a new GLP-1 agonist that increases insulin mRNA expression.
Nedergaard Symposium, Odense, Denmark, January 24, 2002 (Abstract)
Poster presentation
Tip a friend
Fill in the form below to tip a friend about this page.
Subscribe
When this page is updated you will be updated by e-mail.